Trials / Withdrawn
WithdrawnNCT01908764
Pharmacokinetic Study of AL-60371 Otic Suspension in Pediatric Subjects Following Tympanostomy Tube Surgery
An Open-Label, Single Dose, Pharmacokinetic Study of AL-60371 Otic Suspension, 0.3% in Pediatric Subjects Following Tympanostomy Tube Surgery
- Status
- Withdrawn
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 6 Months – 12 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to describe the pharmacokinetics of AL-60371 otic suspension following two posologies of bilateral ototopical doses in pediatric subjects immediately after bilateral tympanostomy tube surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AL-60371 otic suspension |
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2015-01-01
- Completion
- 2015-01-01
- First posted
- 2013-07-26
- Last updated
- 2016-03-08
Source: ClinicalTrials.gov record NCT01908764. Inclusion in this directory is not an endorsement.